This study found a significant reduction in aortic wall area and maximal aortic wall thickness, in patients presenting with ACS with no difference in non-ACS patients with known coronary artery disease, at baseline compared to three-month follow-up and no between group differences, accompanied by reduction in C-reactive protein in both groups, with higher reduction notable in ACS patients. This evidence concerns the gene CRP and coronary artery disorder.